Inhibitor development in an elderly patient with severe factor IX deficiency being treated with ALPROLIX, a recombinant factor IX Fc fusion protein.
Claire ComerfordMaeve P CrowleyNorma CollinsBrid Booth-FlemingAnnmarie Ryan-HallBrid FirtearSusan O'SheaCleona DugganPublished in: Haemophilia : the official journal of the World Federation of Hemophilia (2020)